Marubi Biotech: Net profit of 247 million yuan in 2025, down 27.63% year-on-year

Marubi Biotech announces that in 2025, operating revenue reached 3.46B yuan, a year-on-year increase of 16.48%. Net profit was 247 million yuan, a decrease of 27.63% year-on-year. The company’s board of directors approved a profit distribution plan to distribute a cash dividend of 0.25 yuan per share (tax included) to all shareholders.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin